We use medical products every day. They range from glucose meters and programmable pacemakers, to the pills and products in our medicine cabinets. They include brand and generic drugs, complex biologics, and vaccines. They need to be safe and effective. The FDA is helping to bring scientific advances to the patients who rely on these products every day.

Recent Perspectives on Medical Products Topics

• 01/14/2022 Many Important Drugs Approved in 2021 as COVID-19 Pandemic Continues
• 12/21/2021 Looking Ahead to 2022 as FDA’s Center for Devices and Radiological Health Manages a Sustained Increase in Workload
• 10/14/2021 How CDRH's Digital Transformation Initiative Will Strengthen the Premarket Review Program
• 10/13/2021 FDA's Advanced Manufacturing Initiatives Helping to Provide Quality Human Drugs for Patients
• 10/05/2021 Advancing the Development of Innovative Veterinary Products
• 10/04/2021 Communicating About Medical Device Safety Is Paramount to Public Health
• 09/13/2021 FDA Continues Collaboration with Drug Compounders as Second Anniversary of Compounding Quality Center of Excellence Approaches
• 06/03/2021 Innovative Regenerative Medicine Therapies – Patient Safety Comes First
• 06/01/2021 FDA’s Oncology Center of Excellence Launches National Black Family Cancer Awareness Week
• 04/22/2021 FDA Stresses Critical Importance of Safe Disposal of Medications Ahead of National Prescription Drug Take Back Day
• 04/21/2021 Advancing the Development of Safe and Effective Regenerative Medicine Products
• 04/15/2021 A Year Into the Pandemic: How the FDA’s Center for Devices and Radiological Health is Prioritizing its Workload and Looking Ahead
• 04/12/2021 Vaccine Ready: Addressing COVID-19 Health Disparities among Racial and Ethnic Minority Communities
• 03/31/2021 Accelerating Medical Device Innovation with Regulatory Science Tools
• 03/16/2021 Leveraging Real World Evidence in Regulatory Submissions of Medical Devices
• 03/04/2021 Elastomeric Respirator Innovations Play a Critical Role in Response to COVID-19
• 02/18/2021 Reflections on a Record Year for Novel Device Innovation Despite COVID-19 Challenges
• 02/11/2021 FDA’s Generic Drug Program in 2020 Helped Ensure Availability of High-Quality, Affordable Drugs Amid COVID-19
• 01/08/2021 2020: A Strong Year for New Drug Therapy Approvals – Despite Many COVID-19 Challenges
• 12/08/2020 Project Orbis: Strengthening International Collaboration for Oncology Product Reviews, Faster Patient Access to Innovative Therapies
• 12/01/2020 World AIDS Day 2020: FDA Continues to Drive Advances in Care and Work with the Global Public Health Community
• 10/20/2020 The FDA’s Vaccines and Related Biological Products Advisory Committee and its Role in Advising the Agency on COVID-19 Vaccines
• 09/23/2020 It Just Got Easier for Physicians to Help Their Patients Gain Access to Investigational Treatments
• 08/06/2020 An Exciting New Chapter in OTC Drug History: OTC Monograph Reform in the CARES Act
• 07/22/2020 Potential Risks of Treatment with Unapproved Regenerative Medicine Products
• 07/21/2020 FDA’s Ongoing Work to Support and Advance COVID-19 Diagnostic Test Accuracy and Availability
• 06/11/2020 Rare Disease Therapy Development and Access Remain Top FDA Priorities During COVID-19
• 05/13/2020 FDA Announces Latest Step Toward Finalizing Memorandum of Understanding with States Addressing Compounded Drug Distribution, While Preserving Access
• 03/23/2020 FDA and EMA Collaborate to Facilitate SARS-CoV-2 Vaccine Development
• 02/19/2020 Serving Public Health Paramount in a Successful 2019 for FDA’s Generic Drug Program
• 01/21/2020 Shedding More Light on Sunscreen Absorption
• 01/17/2020 FDA Harnesses Technology and Collaboration to Support Rare Disease Product Development
• 01/06/2020 Innovation in New Drug Approvals of 2019 Advances Patient Care Across a Broad Range of Diseases
• 11/14/2019 Balancing Patient Engagement and Awareness with Medical Device Cybersecurity
• 10/24/2019 To Help Reduce Drug Shortages, We Need Manufacturers to Sell Quality — Not Just Medicine
• 08/27/2019 Delivering Promising New Medicines Without Sacrificing Safety and Efficacy
• 07/15/2019 Preventing Medical Device Shortages by Ensuring Safe and Effective Sterilization in Manufacturing
• 07/11/2019 How the FDA Uses Science to Speed Medical Device Innovation
• 06/13/2019 Ensuring Innovation and Competition for Biologics Leads to More Timely Products for Patients
• 05/17/2019 FDA’s Strengthened Global Inspection Program Helps Ensure Generic Drug Safety
• 05/13/2019 Safety, Efficacy, and Quality Remain Top Priorities as We Continue Our Work to Expand Access to Cost-Saving Generic Drugs for the American Public
• 05/06/2019 Shedding New Light on Sunscreen Absorption
• 05/01/2019 Implementing a Team-Based Approach to Medical Device and Radiological Product Evaluation and Quality
• 04/17/2019 FDA’s Efforts to Advance the Development of Biologics
• 02/28/2019 FDA is Working to Bridge Gaps and Meet Needs for Rare Disease Product Development
• 02/27/2019 2018: A year of Advancing Generic Products and Policies, Laying the Foundation for 2019
• 02/22/2019 The FDA's Oncology Center of Excellence — Quantifying the Patient Experience
• 01/08/2019 CDER’s Work to Ensure Drug Safety is An Ongoing Top Priority
• 01/07/2019 2018: A Year of Innovation, Efficiency, and New Advances in Drug Therapy for the American Public
• 11/30/2018 Inspiring Medical Device Innovation to Combat the Opioid Crisis
• 11/01/2018 The Medical Device Ecosystem and Cybersecurity — Building Capabilities and Advancing Contributions
• 10/03/2018 CDRH FY 2019 Proposed Guidance Development and Retrospective Review
• 07/04/2018 FDA Proposes Process Modernization to Support New Drug Development
• 05/22/2018 The FDA Issues Draft Guidance About the Absorption of Active Ingredients Being Considered for Inclusion in Over-the-Counter Drug Products Applied to the Skin and Marketed without Approved Applications
• 05/04/2018 The FDA is Asking for More Information on Application Forms — Here's Why That's Good for Innovation and Improving Health
• 04/23/2018 New CDER Report Highlights Ongoing Drug Safety Initiatives and Priorities
• 03/27/2018 FDA Blood Supply and Demand Simulation Model Could Help Nation Prepare for Emergencies
• 03/07/2018 Predicting Stem Cell Activity to Ensure Safe and Effective Therapies
• 02/27/2018 Brain Implant for Some Blind People Shows Benefits of FDA'€™s Breakthrough Device Program
• 02/07/2018 2017 Was Another Record-Setting Year for Generic Drugs
• 01/17/2018 Charting Our Course for 2018-2020
• 01/10/2018 Many "€œFirsts" for CDER's 2017 Drug Approvals Reflect Innovation and Enhanced Patient Care
• 03/21/2017 This is Not a Test: RMAT Designation Goes Live
• 09/29/2016 Using Symbols to Convey Information in Medical Device Labeling